NEW DELHI: Hyderabad-based leading vaccine Bharat Biotech has announced that its Covid-19 vaccine candidate, Covaxin, during its tests on animal rhesus macaques, has developed a “robust immune response” to the highly infectious coronavirus, “preventing infections and diseases in primates after large amounts of exposure to the live SARS-CoV-2 virus ”. …
Read More »
Hyderabad-based Bharat Biotech on Friday released study results of its Covid-19 vaccine candidate, Covaxin, which is currently in phase I / II human trials. The results show a reduction in the replication of the virus in the nasal cavity, throat and lung tissues of monkeys. “These results demonstrate protective efficacy …
Read More »
COVAXIN: Bharat Biotech has published the results of a candidate vaccine administered to animals in trials New Delhi: Bharat Biotech, which is developing the COVAXIN coronavirus vaccine in its latest report, has said that an animal study has shown that a candidate vaccine has helped develop a strong immune response …
Read More »
A photo shows an employee showing a vial with the “Gam-COVID-Vac” vaccine against the coronavirus disease, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology in Russia on August 7, 2020. (Reuters ) Bharat Biotech said the results demonstrated the protective efficacy of the Covid-19 vaccine in a …
Read More »
The Center has approved Covaxin coronavirus vaccine from Hyderabad-based Bharat Biotech for phase 2 clinical trials starting on September 7. The trials will be carried out with 380 volunteers, according to a letter sent to Bharat Biotech International by Dr S Eswara Reddy, Joint Controller of Drugs of India. In …
Read More »
It should be noted that Pune IBS has already started Phase II and III of the Oxford COVID vaccine in India last week. About 1,600 volunteers will be enrolled for the critical last stage of the Oxford vaccine trials. AstraZeneca has also started the final phase of testing in the …
Read More »
NEW DELHI: In another grim milestone, the number of active cases in the country surpassed 8 lakh, having risen from the 7 lakh mark in 11 days. It had taken 15 days for active cases to increase from 6 lakh to 7 lakh. There has been a sudden increase in …
Read More »
BHUBANESWAR: Preparations are underway at a hospital here for the start of the second phase of the human clinical trial of ‘Covaxin’, the COVID-19 vaccine indigenous to India, authorities said. “The Phase I trial is still continuing as we are planning to start the Phase II trial shortly,” said Dr. …
Read More »
The whole world is waiting with great anticipation for a ‘safe and effective’ vaccine against the new coronavirus. Currently, three candidate vaccines are in different stages of testing in India. Two homegrown candidate vaccines, Covaxin from Bharat Biotech and ZyCoV-D from Zydus Cadila have already started the phase II clinical …
Read More »